CLINICAL_TRIALS
trial_result
· 2017-03-09
Clinical Trial Update: A Phase 2 Study of OPC-262 in Patients With Type 2 Diabetes [Phase 2]
Summary
A Phase 2 clinical trial evaluating OPC-262 in adults with type 2 diabetes has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Diabetes, Type 2 | Phase 2 | Status: COMPLETED